Avalo Therapeutics logo

Avalo Therapeutics

AVTXNASDAQ

Avalo Therapeutics is a biotechnology company in the healthcare sector on NASDAQ, led by Garry A. Neil, with a market cap of $337.3M. As of Q3 2025, 116% of shares are held by 65 institutional investors, with BVF INC/IL as the largest holder at 10.3%.

Chief Executive OfficerGarry A. Neil
Market Cap$337.3M
Biotechnology
Healthcare
Employees19.0
Country
United States of America

Overview

Overview of institutional ownership in AVTX as of Q3 2025 with a market cap of $167.2M

All Institutions

Institutions
65
Value Held
$194.7M
Shares Held
15.3M
Avg Position
$3.0M
Median Position
$953.3K

Hedge Funds

Hedge Funds
26
Value Held
$130.3M
Shares Held
10.3M
Avg Position
$5.0M
Median Position
$1.9M

Ownership Breakdown

Institutional (non-HF): 38.51%Institutional (non-HF)Hedge Funds: 77.96%Hedge FundsRetail & Other: -
Institutional (non-HF)
38.51%
$64.4M
Hedge Funds
77.96%
$130.3M
Retail & Other
-
-

Based on market cap of $167.2M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in AVTX as of Q3 2025

InstitutionPosition Value
B
BVF INC/IL
Institution
$17.2M
0.70% of portfolio
ORBIMED ADVISORS LLC logo
ORBIMED ADVISORS LLC
Hedge FundSector
$17.1M
0.42% of portfolio
N
Nantahala Capital Management, LLC
Hedge FundMulti-Strategy
$15.7M
0.97% of portfolio
Point72 Asset Management, L.P. logo
Point72 Asset Management, L.P.
Hedge FundMulti-Strategy
$13.4M
0.03% of portfolio
Affinity Asset Advisors, LLC logo
Affinity Asset Advisors, LLC
Hedge FundLong/Short
$12.8M
1.30% of portfolio
C
Caligan Partners LP
Hedge FundActivist
$10.6M
1.47% of portfolio
BALYASNY ASSET MANAGEMENT LLC logo
BALYASNY ASSET MANAGEMENT LLC
Hedge FundMulti-Strategy
$10.4M
0.02% of portfolio
SILVERARC CAPITAL MANAGEMENT, LLC logo
SILVERARC CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
$9.2M
1.33% of portfolio
$8.8M
0.00% of portfolio
RA CAPITAL MANAGEMENT, LLC logo
RA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
$8.4M
0.10% of portfolio

Net Capital Flow

Institutional buying and selling activity for AVTX in Q3 2025

Traded
+$95.1M
Buyers
47
Sellers
9
Total Bought
+$107.7M
Total Sold
$12.6M
Avg Position
$2.9M

Biggest Buyers

InstitutionNet Bought
Point72 Asset Management, L.P. logo
Point72 Asset Management, L.P.
Hedge FundMulti-Strategy
+$13.4M
+1.1M shares
C
Caligan Partners LP
Hedge FundActivist
+$10.6M
+833.3K shares
BALYASNY ASSET MANAGEMENT LLC logo
BALYASNY ASSET MANAGEMENT LLC
Hedge FundMulti-Strategy
+$10.4M
+817.4K shares
SILVERARC CAPITAL MANAGEMENT, LLC logo
SILVERARC CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
+$9.2M
+720.9K shares
+$6.7M
+525.7K shares
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
+$6.1M
+481.7K shares
Affinity Asset Advisors, LLC logo
Affinity Asset Advisors, LLC
Hedge FundLong/Short
+$5.1M
+398.3K shares
ORBIMED ADVISORS LLC logo
ORBIMED ADVISORS LLC
Hedge FundSector
+$4.9M
+382.3K shares
B
BVF INC/IL
Institution
+$4.2M
+327.2K shares
+$3.3M
+258.8K shares

Biggest Sellers

InstitutionNet Sold
Deep Track Capital, LP logo
Deep Track Capital, LP
Hedge FundLong/Short
$5.4M
422.5K shares
RA CAPITAL MANAGEMENT, LLC logo
RA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
$3.4M
270.0K shares
$2.2M
174.5K shares
A
ADAR1 Capital Management, LLC
Hedge FundLong/Short
$919.4K
72.3K shares
UBS Group AG logo
UBS Group AG
Institution
$489.5K
38.5K shares
$79.8K
6.3K shares
$52.1K
4.1K shares
B
BlackRock, Inc.
Institution
$20.9K
1.6K shares
$5.0
1.0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited AVTX in Q3 2025

New Positions
18
New Value
$38.9M
Exited Positions
1
Exited Value
$5.0

New Positions

InstitutionPosition Value
C
Caligan Partners LP
Hedge FundActivist
$10.6M
833.3K shares
SILVERARC CAPITAL MANAGEMENT, LLC logo
SILVERARC CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
$9.2M
720.9K shares
$3.3M
258.8K shares
$2.7M
213.6K shares
S
SUPERSTRING CAPITAL MANAGEMENT LP
Hedge FundLong/Short
$2.4M
188.1K shares
Ally Bridge Group  LLC logo
Ally Bridge Group LLC
Hedge FundSector
$2.3M
178.1K shares
Boxer Capital Management, LLC logo
Boxer Capital Management, LLC
Hedge FundLong/Short
$1.6M
125.0K shares
Exome Asset Management LLC logo
Exome Asset Management LLC
Hedge FundSector
$1.3M
100.0K shares
$1.3M
100.0K shares
$1.1M
85.2K shares

Exited Positions

InstitutionPrevious Position
$5.0
1.0 shares

Options Activity

Institutions with the largest Call and Put options positions in AVTX as of Q3 2025

Call Positions
2
Call Value
$1.3M
Put Positions
3
Put Value
$608.0K

Call Positions

InstitutionPosition Value
DLD Asset Management, LP logo
DLD Asset Management, LP
Hedge FundMulti-Strategy
$673.0K
531.0 contracts
$644.4K
507.0 contracts

Put Positions

InstitutionPosition Value
DLD Asset Management, LP logo
DLD Asset Management, LP
Hedge FundMulti-Strategy
$296.6K
234.0 contracts
$172.9K
136.0 contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$138.5K
109.0 contracts

Most Committed Institutions

Institutions with AVTX as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
3.15%
$3.4M
S
SUPERSTRING CAPITAL MANAGEMENT LP
Hedge FundLong/Short
2.36%
$2.4M
Ally Bridge Group  LLC logo
Ally Bridge Group LLC
Hedge FundSector
1.90%
$2.3M
C
Caligan Partners LP
Hedge FundActivist
1.47%
$10.6M
SILVERARC CAPITAL MANAGEMENT, LLC logo
SILVERARC CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
1.33%
$9.2M
Affinity Asset Advisors, LLC logo
Affinity Asset Advisors, LLC
Hedge FundLong/Short
1.30%
$12.8M
N
Nantahala Capital Management, LLC
Hedge FundMulti-Strategy
0.97%
$15.7M
Exome Asset Management LLC logo
Exome Asset Management LLC
Hedge FundSector
0.86%
$1.3M
B
BVF INC/IL
Institution
0.70%
$17.2M
Boxer Capital Management, LLC logo
Boxer Capital Management, LLC
Hedge FundLong/Short
0.52%
$1.6M

Hedge Fund Spotlight

Discover hedge funds investing in AVTX

Ally Bridge Group  LLC logo
Ally Bridge Group LLC
Hedge FundSector
Portfolio ManagerSlanix Paul T Alex
Portfolio Value
$119.4M
Positions
18
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Healthcare: 83.50%Healthcare
Avalo Therapeutics logo

Position in Avalo Therapeutics

Market Value
$2.3M
Shares Held
178.1K
Portfolio Weight
1.90%
Owned Since
2025-Q3
Top HoldingSectorMarket ValueWeight
Biotechnology
Healthcare
$20.4M17.12%
Biotechnology
Healthcare
$15.0M12.54%
Biotechnology
Healthcare
$12.1M10.13%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.